These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 35580963)

  • 1. Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions.
    Macias RIR; Cardinale V; Kendall TJ; Avila MA; Guido M; Coulouarn C; Braconi C; Frampton AE; Bridgewater J; Overi D; Pereira SP; Rengo M; Kather JN; Lamarca A; Pedica F; Forner A; Valle JW; Gaudio E; Alvaro D; Banales JM; Carpino G
    Gut; 2022 Aug; 71(8):1669-1683. PubMed ID: 35580963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.
    Gibiino G; Fabbri C; Fagiuoli S; Ianiro G; Fornelli A; Cennamo V
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):730-741. PubMed ID: 28272710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice.
    Saengboonmee C; Obchoei S; Sawanyawisuth K; Wongkham S
    Expert Rev Anticancer Ther; 2023 May; 23(5):517-530. PubMed ID: 37052887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
    Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
    Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic biomarkers in cholangiocarcinoma.
    Macias RIR; Kornek M; Rodrigues PM; Paiva NA; Castro RE; Urban S; Pereira SP; Cadamuro M; Rupp C; Loosen SH; Luedde T; Banales JM
    Liver Int; 2019 May; 39 Suppl 1():108-122. PubMed ID: 30843325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of cholangiocarcinoma.
    Bergquist A; von Seth E
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):221-32. PubMed ID: 25966423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomical, histomorphological and molecular classification of cholangiocarcinoma.
    Kendall T; Verheij J; Gaudio E; Evert M; Guido M; Goeppert B; Carpino G
    Liver Int; 2019 May; 39 Suppl 1():7-18. PubMed ID: 30882996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
    Yao D; Kunam VK; Li X
    J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation, diagnosis and staging of cholangiocarcinoma.
    Forner A; Vidili G; Rengo M; Bujanda L; Ponz-Sarvisé M; Lamarca A
    Liver Int; 2019 May; 39 Suppl 1():98-107. PubMed ID: 30831002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and bile biomarkers for cholangiocarcinoma.
    Alvaro D
    Curr Opin Gastroenterol; 2009 May; 25(3):279-84. PubMed ID: 19396965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.
    Puik JR; Meijer LL; Le Large TY; Prado MM; Frampton AE; Kazemier G; Giovannetti E
    Pharmacogenomics; 2017 Sep; 18(14):1343-1358. PubMed ID: 28832247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of bile as a biomarker via ferroptosis and cysteine prenylation in cholangiocarcinoma; role of diagnosis and differentiation from benign biliary disease.
    Han JY; Ahn KS; Baek WK; Suh SI; Kim YH; Kim TS; Kang KJ
    Surg Oncol; 2020 Sep; 34():174-181. PubMed ID: 32891325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
    Liau JY; Tsai JH; Yuan RH; Chang CN; Lee HJ; Jeng YM
    Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions.
    Cossiga V; Guarino M; Capasso M; Morisco F
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand.
    Chamadol N; Khuntikeo N; Thinkhamrop B; Thinkhamrop K; Suwannatrai AT; Kelly M; Promthet S
    BMJ Open; 2019 Mar; 9(3):e023217. PubMed ID: 30898798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in targeted therapy of cholangiocarcinoma.
    Li Y; Yu J; Zhang Y; Peng C; Song Y; Liu S
    Ann Med; 2024 Dec; 56(1):2310196. PubMed ID: 38359439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs.
    Spolverato G; Glavas D; Hewitt DB; Brown ZJ; Capelli G; Bergamo F; Rizzato MD; Pawlik TM
    Expert Opin Pharmacother; 2022 Mar; 23(4):473-481. PubMed ID: 34964678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Banking on the future: biobanking for "omics" approaches to biomarker discovery for Opisthorchis-induced cholangiocarcinoma in Thailand.
    Mulvenna J; Yonglitthipagon P; Sripa B; Brindley PJ; Loukas A; Bethony JM
    Parasitol Int; 2012 Mar; 61(1):173-7. PubMed ID: 21855650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches in search for biomarkers of cholangiocarcinoma.
    Mocan LP; Ilieș M; Melincovici CS; Spârchez M; Crăciun R; Nenu I; Horhat A; Tefas C; Spârchez Z; Iuga CA; Mocan T; Mihu CM
    World J Gastroenterol; 2022 Apr; 28(15):1508-1525. PubMed ID: 35582128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future directions in the treatment of cholangiocarcinoma.
    Zhu AX
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.